Combined Rituximab and Daratumumab Induces Remission in Refractory Post-Transplant Crescentic IgA Nephropathy.
- DOI
- 10.1016/j.ajt.2026.10.031
- Published
- 2026 Nov 9
- Container
- American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ajt.2026.10.031,
title = {Combined Rituximab and Daratumumab Induces Remission in Refractory Post-Transplant Crescentic IgA Nephropathy.},
author = {Zhang X and Wei C and Zheng G and Yao D and Wang M and Zhou Q and Wang R and Chen J and Hu W and Wu J and Cui Y},
year = {2026},
journal = {American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons},
doi = {10.1016/j.ajt.2026.10.031},
url = {https://doi.org/10.1016/j.ajt.2026.10.031}
}RIS
TY - JOUR TI - Combined Rituximab and Daratumumab Induces Remission in Refractory Post-Transplant Crescentic IgA Nephropathy. AU - Zhang X AU - Wei C AU - Zheng G AU - Yao D AU - Wang M AU - Zhou Q AU - Wang R AU - Chen J AU - Hu W AU - Wu J AU - Cui Y PY - 2026 JO - American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons DO - 10.1016/j.ajt.2026.10.031 UR - https://doi.org/10.1016/j.ajt.2026.10.031 ER -
APA
X, Z., C, W., G, Z., D, Y., M, W., Q, Z., R, W., J, C., W, H., J, W., & Y, C. (2026). Combined Rituximab and Daratumumab Induces Remission in Refractory Post-Transplant Crescentic IgA Nephropathy.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. https://doi.org/10.1016/j.ajt.2026.10.031
Source records
- pubmed · retrieved 2026-11-10T11:51:51.565Z